These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1722452)

  • 21. Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis.
    Espinoza CG; Pillarisetti SG; Azar HA
    Ann Clin Lab Sci; 1984; 14(6):467-73. PubMed ID: 6210034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The occurrence and significance of the presence of alpha fetoprotein (AFP) and Australia antigen (HBsAg) in the serum of 392 patients with chronic disease and primary malignant neoplasms of the liver].
    Stajić M; Milosavljević J
    Acta Med Iugosl; 1978; 32(3):243-51. PubMed ID: 80098
    [No Abstract]   [Full Text] [Related]  

  • 23. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
    Jee SH; Ohrr H; Sull JW; Samet JM
    J Natl Cancer Inst; 2004 Dec; 96(24):1851-6. PubMed ID: 15601641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
    Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-fetoprotein and its concanavalin A affinity in acute exacerbation of chronic hepatitis B.
    Wang SS; Govindarajan S; Lee SD; Ashcavai M
    Am J Gastroenterol; 1989 Jan; 84(1):46-8. PubMed ID: 2463755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC; Chan CS; Chen GH
    Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
    Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
    J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma.
    Taketa K; Endo Y; Sekiya C; Tanikawa K; Koji T; Taga H; Satomura S; Matsuura S; Kawai T; Hirai H
    Cancer Res; 1993 Nov; 53(22):5419-23. PubMed ID: 7693340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatitis B and primary cancer of the liver in intertropical Africa].
    Coursaget P; Yvonnet B; Barres JL; Perrin J; Tortey E; Diop B; Kocheleff P; Duflo B; M'Boup S; Diop-Mar I
    Rev Epidemiol Sante Publique; 1985; 33(4-5):267-75. PubMed ID: 2419946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HBsAg, aflatoxins and primary hepatocellular carcinoma.
    Olubuyide IO; Maxwell SM; Hood H; Neal GE; Hendrickse RG
    Afr J Med Med Sci; 1993 Sep; 22(3):89-91. PubMed ID: 7839921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary hepatocellular carcinoma with hepatitis B virus infection in a 16-year-old noncirrhotic patient.
    Gasser RW; Judmaier G; Zur Nedden D; Aufschnaiter M; Hofstaedter F
    Am J Gastroenterol; 1983 May; 78(5):305-8. PubMed ID: 6189392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma and the hepatitis B virus: a study of British patients.
    Dunk AA; Spiliadis H; Sherlock S; Fowler MJ; Monjardino JP; Scheuer PJ; Karayiannis P; Thomas HC
    Q J Med; 1987 Feb; 62(238):109-16. PubMed ID: 2821569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
    Radhika NS; Duseja A; Rajwanshi A; Gupta SK; Sehgal S; Suri S; Chawla Y
    Trop Gastroenterol; 2004; 25(3):116-20. PubMed ID: 15682657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The detection of alpha-fetoprotein in HBs Ag and HBe Ag carriers.
    Panoyotopoulos S; Yiannacopoulos T; Margari-Papanicolaou P; Christou A
    Allergol Immunopathol (Madr); 1982; 10(1):1-4. PubMed ID: 6177229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of serum alpha-fetoprotein determination. Experiences with our own radioimmunoassay].
    Lamerz R; Schmalhorst U; Grunst J; Fateh-Moghadam A; Eisenburg J
    Fortschr Med; 1976 Apr; 94(12):702-10. PubMed ID: 61154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
    Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
    J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
    Okuda H; Obata H; Motoike Y; Hisamitsu T
    Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
    Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.